flurbiprofen has been researched along with Cancer of the Thyroid in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of thyroid cancer, a most common tumor in the endocrine system, has increased in recent years." | 1.72 | Flurbiprofen inhibits cell proliferation in thyroid cancer through interrupting HIP1R-induced endocytosis of PTEN. ( Jiang, L; Liang, Y; Yang, N; Yang, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, N | 1 |
| Liang, Y | 1 |
| Yang, P | 1 |
| Jiang, L | 1 |
1 other study available for flurbiprofen and Cancer of the Thyroid
| Article | Year |
|---|---|
Flurbiprofen inhibits cell proliferation in thyroid cancer through interrupting HIP1R-induced endocytosis of PTEN.
Topics: Adaptor Proteins, Signal Transducing; Cell Proliferation; Cells, Cultured; Cyclooxygenase Inhibitors | 2022 |